Chairman of medmix Board of Director, Gregoire Poux-Guillaume to take on an external CEO mandate, will not stand for re-election as Chairman at AGM 2023
Ad hoc announcement pursuant to Art. 53 LR
medmix publishes a midyear report as well as an annual report.
Ad hoc announcement pursuant to Art. 53 LR
Ad hoc announcement pursuant to Art. 53 LR
medmix is relocating production to other countries following an initial negative decision on sanctions unilaterally introduced by Poland. It is medmix’ firm belief that the sanctions against its entity in Poland are erroneous. The company continues its appeal process, with the full support of the Swiss government administration. medmix is not affected by any other sanctions and is free to develop its business globally.
medmix Drug Delivery introduces PiccoJect™, a disposable two-step autoinjector designed for subcutaneous injection. The device is being developed in two variants (PiccoJect™ 100 and PiccoJect™ 225) for a standard 1 ml long or 2.25 ml pre-filled glass or plastic syringes. With a focus on patient centric design and a commitment to sustainability, PiccoJect™ is composed of only eight parts and features an ergonomic shape and a large wrap-around drug window.
Ad hoc announcement pursuant to Art. 53 LR
medmix suspends the operations of its manufacturing site in Wroclaw, Poland as a result of sanctions levied by the Polish government. The sanctions apply to medmix’ minority shareholder, Viktor Vekselberg, but have been extended to medmix Poland, even though Mr. Vekselberg has no control or ownership of any medmix entities and is deprived of all his economic rights in medmix.
medmix Switzerland Ltd., formerly known as Sulzer Mixpac Ltd., operates globally in the field of dispensers for the industrial sector. In recent times, inferior-quality copies of the well-known COX brand industrial dispensers have increasingly been discovered. These copies by other manufacturers are not subject to medmix's strict quality controls and are therefore not covered by its warranty. In the interests of its clients, medmix will continue to take legal steps against all such copies.
With the MIXPAC™ F-System, medmix provides a complete and compatible solution that meets the demanding needs for multifunctional industrial applications. Determined in pursuing its sustainability objectives, medmix upgrades the proven system with a bayonet ring based on 100% post-consumer recycled (PCR) polypropylene.
An internal Life Cycle Assessment (LCA) was conducted by the ECODESIGN company for medmix, to assess the environmental aspects and impacts of the materials, manufacturing and distribution of the MIXPAC™ ecopaCC™ foil cartridge versus the medmix 600ml 1:1 polypropylene solid cartridge.
Ad hoc announcement pursuant to Art. 53 LR
medmix Switzerland Ltd., formerly known as Sulzer Mixpac Ltd., operates globally in the field of static mixing tips, cartridges and dispensing devices for the dental sector. Recently, substantially identical copies of the static mixing tips for two-component cartridges and syringes have been discovered, including the patent-protected revolutionary T-Mixer mixing tip.
medmix Switzerland Ltd., formerly known as Sulzer Mixpac Ltd., operates globally in the field of static mixing tips, cartridges and dispensing devices for the dental sector. In recent times, substantially identical copies of the static mixing tips for two-component cartridges and syringes have been increasingly discovered.
Putting its commitment to Sustainability into practice, medmix launches the first cartridge made from 100% post‐consumer recycled polypropylene (PCR PP), giving medmix customers a new option to reduce their environmental impact and meet their sustainability goals.
Ad hoc announcement pursuant to Art. 53 LR